
Eagle’s Eye View: Saturday, November 11 — Daily Wrap Up | AHA 2023
Eagle's Eye View: Your Weekly CV Update From ACC.org
00:00
Introduction
Experts discuss the top-line results of the select trial, which showed a 20% reduction in cardiovascular death, myocardial infarction, and stroke with the use of semaglutide in obese patients with cardiovascular disease.
Transcript
Play full episode